Epidemiology of cancer in childhood;Épidémiologie des cancers de l'enfant

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 4, 2003, Pages 711-741

  Sommelet, Danièle ^a   Lacour, Brigitte ^b   Clavel, Jacqueline ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

Author keywords

Child; Environment; Epidemiology; Genetics; Neoplasms

Indexed keywords

EID: 84879828764     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)34001-4     Document Type: Article

References (109)

1. KRAMAROVA E., STILLER CA - The International Classification of Childhood Cancer. Int. J. Cancer, 1996, 68, 759-65.
2. SOMMELET D., LACOUR B. - Childhood Cancer Registry of Lorraine, 1983-92. In: Parkin DM, Kramarova E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureschi S, Stiller CA, editors. • International Incidence of Childhood Cancer, Vol II. IARC Scientific Publications, no 144, Lyon, 1998, 273-5.
3. PARKIN D.M., KRAMAROVA E., DRAPER G.J. et al, editors. - International Incidence of Childhood Cancer, Vol II. IARC Scientific Publications, no 144, Lyon, 1998.
4. STILLER CA., PARKIN D.M. - Geographic and ethnic variations in the incidence of childhood cancer. Br. Med. Bull., 1996, 52, 682-703.
5. BHATIA S., SATHER H.N., HEERBMA N.A., TRIGG M.E., GAYNON P.S., ROBISON L.L. - Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood, 2002, 700, 1957-64.
6. BITHELL J.F., VINCENT T.H. - Geographical variations in childhood leukaemia incidence. In: Elliott P, Wakefield JC, Best NG, Briggs DJ, eds. Spatial Epidemiology. Oxford: Oxford University Press, 2000, 317-32.
7. PEARCE M.S., PARKER L. - Childhood cancer registrations in the developing world: still more boys than girls. Int. J. Cancer, 2001, 91, 402-6.
8. TERRACINI B., COEBERGH J.W., GATTA G. et al. - Childhood cancer survival in Europe: an overview. Eur. J. Cancer, 2001, 37, 810-6.
9. MAGNANI C, GATTA G., CORAZZIARI I. et al. - Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis. Eur. J. Cancer, 2001, 37, 678-86.
10. RIES LAG., SMITH M.A., GURNEY J.G. et al, eds. - Cancer incidence and survival among children and adolescents: United States SEER Programm 1975-1995. NIH pub no 99-4949, Bethesda, MD, National Cancer Institute, SEER Programm, 1999, 157-64.
11. GATTA G., CAPOCACCIA R., COLEMAN M.P., RIBS LAG, BERRINO F. - Childhood Cancer Survival in Europe and the United States. Cancer, 2002, 95, 1767-72.
12. LINET M.S., RIES LAG., SMITH M.A., TARONE R.E., DEVESA S.S. - Cancer Surveillance Series: Recent Trends in Childhood Cancer Incidence and Mortality in the United States. J. Natl. Cancer Inst., 1999, 91, 1051-8.
13. MERTENS A.C., YASUI Y, NEGLIA IP et al. - Late mortality experience in five-year survivors of childhood and adolescent cancers: the Childhood Cancer Survivor Study. J. Clin. Oncol., 2001, 19, 3163-72.
14. MÖLLER T.R., GARWICZ S., BARLOW L. et al, for the Association of the Nordic Cancer Registries and the Nordic Society for Pediatric Hematology and Oncology. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a populationbased study in the Nordic Countries. J. Clin. Oncol, 2001, 19, 3173-81.
15. LITTLE J. - Epidemiology of childhood cancers. IARC Scientific Publication no 149, Lyon, 1999.
16. NICHOLS K.E, LI F.R, HABER D.A., DILLER L. - Childhood cancer predisposition: applications of molecular testing and future implications. J Pediatr., 1998, 132, 389-97.
17. NAROD S.A., STILLER C, LENOIR G.M. - An estimate of the heritable fraction of childhood cancer. Br. J. Cancer, 1991, 63, 993-9.
18. KNUDSON A.G. Jr. - Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci., 1971, 68, 820-3.
19. ZUCKER J.M., DESJARDINS L., DOZ F. - Peadiatric update: Retinoblastoma. Eur. J. Cancer, 1998, 34, 1045-9.
20. MAIRAL A., PINGLIER E., GILBERT E., PETER M., VALIDIRE P., DESJARDINS L., DOZ F., AURIAS A., COUTURIER I. - Genes Chromosomes & Cancer, 2000, 28, 370-9.
21. VARLEY J.M., EVANS D.G., BIRCH J.M. - Li-Fraumeni Syndrome: a molecular and clinical review. Br. J. Cancer, 1997, 76, 1-14.
22. HISADA M., GARBER J.E., FUNG C.Y, FRAUMENI J.F. JR., LI F.P. - Multiple primary cancers in families with Li-Fraumeni syndrome. J. Natl. Cancer Inst., 1998, 90, 606-11.
23. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am. J. Hum. Genet., 1995, 57, 1233-41.
24. EISINGER F., THOUVENIN D, BIGNON Y.J. et al. - Considerations on the organization of oncologic-genetic consultations (a first step towards the publication of clinical practice guidelines). Bull. Cancer, 1995, 82, 865-78.
25. RUBENSTEIN A.E., KORF BR, Eds. - Neurofibromatoses: a handbook for patients, families, and health-care professionals. New York: Thieme Medical Publishers, Inc, 1990.
26. PINSON S., CRÉANGE A., BARBAROT S. et al, pour le réseau NF-France. - Neurofibromatose 1: recommandations de prise en charge. Arch. Pediatr., 2002, 9, 49-60.
27. SORENSEN S.A., MULVIHILL II, NIELSEN A. - Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N. Engl. J. Med., 1986, 314, 1010-5.
28. MIKAELOFF Y, CHAIX Y, GRILL I et al. - Les gliomes des voies optiques dans la neurofibro - matose de type 1. Etude longitudinale de 30 cas suivis dans deux consultations multidiscipli - naires. Arch. Pediatr., 2002, 5, 797-804.
29. RASMUSSEN S.A., FRIEDMAN J.M. - NF1 gene and neurofibromatosis 1. Am. J. Epidemiol, 2000, 151, 33-40.
30. BAY J.O., UHRHAMMER N, STOPPA-LYONNET D., HALL I. - Rôle du gène ATM dans la prédisposition génétique aux cancers. Bull. Cancer, 2000, 87, 29-34.
31. GILAD S., CHESSA L., KHOSRAVI R., RUSSELL P. et al. - A Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am. J. Hum. Genet., 1998, 62, 551-561.
32. SANDOVAL G, SWIFT M. - Treatment of lymphoid malignancies in patients with ataxiatelangiectasia. Med. Pediatr. Oncol., 1998, 31, 491-7.
33. ALTMANN A.E., HALLIDAY J.L., GILES G.G. - Associations between congenital malformations and childhood cancer. A register-based case-control study. Br. J. Cancer, 1998, 78, 1244-9.
34. AL-KASIM F., DOYLE J.J, MASSEY G.V., WEINSTEIN H. J., ZIPURSKY A. - Incidence and treatment of potentially lethal disease in transient leukemia of Down syndrome: a Pediatric Oncology Group study. J. Ped. Hematol. Oncol., 2002, 24, 9-13.
35. WECHSLER J., GREENE M., MCDEVITT M.A., et al - Acquired mutations in GATAI in the megakaryoblastic leukemia of Down syndrome. Nat. Genet., 2002, 32, 148-52.
36. LANGE B.J., KOBRINSKY N., BARNARD D.R. et al. - Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood, 1998, 91, 608-15.
37. HASLE H., CLEMMENSEN I.H., MIKKELSEN M. - Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet, 2000, 355, 165-9.
38. SATGE D., SASCO A.J., CURE H., LEDUC B., SOMMELET D., VEKEMANS M.J. - An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature. Cancer, 1997, 80, 929-35.
39. SATGE D., SOMMELET D., GENEIX A., NISHI M., MALET P., VEKEMANS M. - A tumor profile in Down syndrome. Am. J. Med. Genet., 1998, 78, 207-16.
40. SATGE D., SASCO A.J., CARLSEN N.L. et al. - A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res., 1998, 58, 448-52.
41. CHOYKE P.L., SIEGEL M.J., CRAFT A.W., GREEN D.M., DEBAUN M.R. - Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr. Oncol, 1999, 52, 196-200.
42. CHAO L.Y., HUFF V., STRONG L.C., SAUNDERS G.F. - Mutation in the PAX6 gene in twenty patients with aniridia. Hum. Mutat., 2000, 15, 332-9.
43. DILLER L., GHAHREMANI M., MORGAN J. et al. - Constitutional WT1 mutations in Wilms' tumor patients. J. Clin. Oncol., 1998, 16, 3634-40.
44. LEE S.B., HABER D.A. - Wilms tumor and the WT1 gene. Exp. Cell. Res., 2001, 264, 74-99.
45. RUDIN G, PRITCHARD J., FERNANDO O.N., DUFFY P.G., TROMPETER R.S. - Renal transplantation in the management of bilateral Wilms' tumour (BWT) and of Denys-Drash syndrome (DDS). Nephrol. Dial. Transplant., 1998, 13, 1506-10.
46. MÄHER E.R., REIK W. - Beckwith-Wiedemann syndrome: imprinting in clusters revisited. J. Clin. Invest., 2000, 105, 247-52.
47. DEBAUN M.R., TUCKER M.A. - Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann Syndrome Registry. J. Pediatr., 1998, 132, 398-400.
48. SHNBID H., VASQUEZ M.P., VACHER G., GOURMELEN M., CABROL S., LE BOUC Y. - The Beck with - Wiedeman syndrome phenotype and the risk of cancer. Med Pediatr. Oncol., 1997, 28, 411-5.
49. SLAVOTINEK A., GAUNT L., DONNAI D. - Paternally inherited duplications of Upl5.5 and Beckwith-Wiedemann Syndrome. J. Med. Genet., 1997, 34, 819-26.
50. PERRILLAT F., CLAVEL X, JAUSSENT I. et al. - Family cancer history and risk of childhood acute leukemia (France). Cancer Causes Control, 2001, 12, 935-41.
51. WINTHER J.F., SANKILA R., BOICE J.D. et al. - Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. Lancet., 2001, 358, 711-7.
52. HEMMINKI K., JIANG Y. - Risks among siblings and twins for childhood acute lymphoid leukaemia: results from the Swedish Family-Cancer Database. Leukemia, 2002, 16, 297-8.
53. LICHTENSTEIN P., HOLM N.V., VERKASALO P.K. et al. - Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med, 2000, 343, 78-85.
54. MURPHY M.F., WHITEMAN D., HEY K. et al. - Childhood cancer incidence in a cohort of twin babies. Br. J. Cancer., 2001, 84, 1460-2.
55. ALEXANDER F.E., PATHEAL S.L., BIONDI A., et al - Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res., 2001, 61, 2542-6.
56. CIMINO G., RAPANOTTI M.G, BIONDI A. et al. - Enfant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res., 1997, 57, 2879-83.
57. MEINERT R., SCHUZ J., KALETSCH U., KAATSCH P., MICHAELIS J. - Leukemia and non - Hodgkin's lymphoma in childhood and exposure to pesticides: results of a register-based case-control study in Germany. Am. J. Epidemiol, 2000, 151, 639-46.
58. Ross J.A., POTTER J.D., REAMAN G.H., PENDERGRASS T.W., ROBISON L.L. - Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control, 1996, 7, 581-90.
59. Ross J.A. - Dietary flavonoids and the MLL gene: A pathway to infant leukemia? Proc. Natl. Acad. Sci USA, 2000, 97, 4411-3.
60. BONAÏTI-PELLIE G., CHOMPRET A., TOURNADE M.F. et al. - Genetics and Epidemiology of Wilms'Tumor: the French Wilms' Tumor Study. Med Ped. Oncol, 1992, 20, 284-91.
61. SHIBATA Y, YAMASHITA S., MASYAKIN V.B., PANASYUK G.D., NAOATAKI S. - 15 years after Chernobyl: new evidence of thyroid cancer. Lancet, 2001, 358, 1965-6.
62. COTERILL S.J., PARKER L., MALCOLM A.J., REID M., MORE L., CRAFT A.W. - Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br. J. Cancer, 2000, 83, 397-403.
63. NOSHCHENKO A.G., ZAMOSTYAN P.V., BONDAR O.Y, DROZDOVA V.D. - Radiation-induced leukemia risk among those aged 0-20 at the time of the Chernobyl accident: a case-control study in the Ukraine. Int. J. Cancer, 2002, 99, 609-18.
64. PARKIN D.M., CARDIS E., MASUYER E., et al - Childhood leukaemia following the Chernobyl accident: the European Childhood Leukaemia-Lymphoma Incidence Study (ECLIS). Eur. J. Cancer, 1992, 29A, 87-95.
65. PETRIDOU E., TRICHOPOULOS D., DESSYPRIS N. et al. - Infant leukaemia after in utero exposure to radiation from Chernobyl. Nature, 1996, 382, 352-3.
66. GARDNER M.J., SNEE M.P., HALL A.J., POWELL C.A., DOWNES S., TERRELL J.D. - Results of case-control study of leukemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ, 1990, 300, 423-9.
67. DOLL R. - The Seascale cluster: a probable explanation. Br J Cancer, 1999, 81, 3-5.
68. GUIZARD A.V., BOUTOU O., POTTIER D. et al. - The incidence of childhood leukaemia around the La Hague nuclear waste reprocessing plant (France): a survey for the years 1978-1998. J. Epidemiol. Community Health., 2001, 55, 469-74.
69. LUBIN J.H., LINET M.S., BOICE J.D. JR. et al. - Case-control study of childhood acute lymphoblastic leukemia and residential radon exposure. J. Natl Cancer Inst., 1998, 90, 294-300.
70. LINET M.S., HATCH E.E., KLEINERMAN R.A. et al. - Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N. Engl. J. Med, 1997, 337, 1-7.
71. AHLBOM I.I., CARDIS E., GRBEN A., LINET M., SAVITZ D., SWERDLOW A. - Review of the Epidemiologic Literature on EMF and Health. Environ Health Perspect, 2001, 109, 911-33.
72. INSKIP P.D., TARONE R.E., HATCH E.E. et al. - Cellular-telephone use and brain tumors. N. Engl. J. Med, 2001, 344, 79-86.
73. CLAVEL I, FOURME E., HARTMANN O., JOUGLA E., LACOUR B., QUENEL P. - Analyse d'un agrégat de cas de cancers dans l'école Franklin Roosevelt de Vincennes. Rapport final. In VS, Inserm, mai 2002.
74. HERBST A.L., ULFELDER H., POSKANZER D.C. - Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med, 1971, 284, 878-81.
75. SWERDLOW A.J., HIGGINS C.D., ADLARD P., PREECE M.A. - Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet, 2002, 360, 273-77.
76. PARKER L., COLE M., CRAFT A.W., HEY E.N. - Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study. BMJ, 1998, 316, 189-93.
77. ROMAN E., FEAR N.T., ANSELL P. et al. - Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. Br. J. Cancer, 2002, 86, 63-9.
78. SORAHAN T., MCKINNEY P.A., MANN J.R. et al. - Childhood cancer and parental use of tobacco: findings from the inter-regional epidemiological study of childhood cancer (IRESCC). Br. J. Cancer, 2001, 84, 141-6.
79. INFANTB-RIVARD C., FORTIER I., OLSON E. - Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia. Br. J. Cancer, 2000, 83, 1559-64.
80. INFANTB-RIVARD C., KRAJINOVIC M., LABUDA D., SINNETT D. - Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Quebec, Canada). Cancer Causes Control, 2000, 11, 547-53.
81. ROBISON L.L., BUCKLEY J.D., DAIGLE A.E et al. - Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer, 1989, 63, 1904-11.
82. DOCKERTY J.D., DRAPER G., VINCENT T., ROWAN S.D., BUNCH K.J. - Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int. J. Epidemiol., 2001, 50, 1428-37.
83. SCHÜZ I., KAATSCH P., KALTESCH U, MEINERT R., MICHAELIS I. - Association of childhood cancer with factors related to pregnancy and birth. In. J. Epidemiol, 1999, 28, 631-39.
84. DEBAUN M.R., GURNEY J.G. - Environmental exposure and cancer in children. A conceptual framework for the pediatrician. Pediatr. Clin. North Am., 2001, c48, 1215-21.
85. PERRILLAT F., CLAVEL I, JAUSSENT I. et al. - Breast-feeding, fetal loss and childhood acute leukaemia. Eur. J. Pediatr., 2002, 161, 235-7.
86. GREAVES M.F. - Aetiology of acute leukemia. Lancet, 1997, 349, 344-9.
87. NEGLIA J.P., LINET M.S., SHU X.O. et al. - Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br. J. Cancer, 2000, 82, 234-40.
88. PERRILLAT F., CLAVEL I, AUCLERC M.F, et al - Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br. J. Cancer, 2002, 86, 1064-9.
89. KINLEN L.J., DICKSON M., STILLER C.A. - Childhood leukaemia and non-Hodgkin's lymphoma near large rural construction sites, with a comparison with Sellafield nuclear site. BMJ, 1995, 310, 763-8.
90. STILLER CA., BOYLE P.J. - Effect of population mixing and socioeconomic status in England and Wales, 1979-85, on lymphoblastic leukaemia in children. BMJ, 1996, 313, 1297-300.
91. Ross J.A., COPPES M.J., ROBISON L.L. - Population density and risk of childhood acute lymphoblastic leukaemia. Lancet, 1999, 354, 532.
92. ALEXANDER F.E., BOYLE P., CARLI P.M. et al. - Population density and childhood leukaemia: results of the EUROCLUS Study. Eur. J. Cancer, 1999, 35, 439-44.
93. NEOLIA IP, FRIEDMAN D.L., YASUI Y. et al. - Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J. Nat. Cancer Inst., 2001, 93, 618-29.
94. Pui C.H., RELLINO M.V., RIVERA G.K. et al. - Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia, 1995, 9, 1990-6.
95. SOCIE G., CURTIS R.E., DEEG H.J., et al - New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J. Clin. Oncol, 2000, 18, 348-57.
96. NG A.K., BERNARDO M.V., WELLER E. et al. - Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood, 2002, 100, 1989-96.
97. LA VECCHIA C., LEVI F., LUCCHINI F., LAGIOU P., TRICHOPOULOS D., NEGRI E. - Trends in childhood cancer mortality as indicators of the quality of medical care in the Developed World. Cancer, 1998, 83, 2223-7.
98. BIRCH J.M., ALSTON R.D., KELSEV A.M., QUINN M J., BABB P., MCNALLY R.J.Q. - Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br. J. Cancer, 2002, 87, 1267-74.
99. STILLER C. - Epidemiology of cancer in adolescents. Med Pediatr Oncol, 2002, 39, 149-55.
100. SMITH M. A., GURNEY IG, RIES L.A.G. - Cancer among adolescents 15-19 years old. In, Ries Lag, Smith MA, Gurney JG, et al, eds. Cancer incidence and survival among children and adolescents: United States SEER Programm 1975-1995. NIH pub no 99-4949, Bethesda, MD, National Cancer Institute, SEER Programm, 1999, 157-64.
101. NACHMAN J., SATHER H.N., BUCKLEY J.D. et al. - Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblasts leukemia protocols. Results of treatment. Cancer, 1993, 71, 3377-85.
102. BOISSEL N., AUCLERC M.F., LHÉRITIER V. et al. - Should adolescents (15-20 years) with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J. Clin. Oncol., soumis à publication.
103. BLEYER W.A. - Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med. Pediatr. Oncol, 2002, 38, 1-10.
104. ROBISON L.L., MERTENS A.C., BOICE J.D. et al. - Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr. Oncol, 2002, 38, 229-39.
105. KRISCHER J.P., EPSTEIN S., CUTHBERTSON D.D., GOORIN A.M., EPSTEIN M.L., LIPSHULTZ S.E. - Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J. Clin. Oncol., 1997, 15, 1544-52.
106. GRENIER M.A., LIPSHULTZ S.E. - Epidemiology of anthracycline cardiotoxicity in children and adults. Semin. Oncol., 1998, 25, 72-85.
107. GEBHARD F., LETHOR J.P., SOMMELET D. - Epidemiological study of early and late anthracycline (A) induced cardiotoxicity in 161 patients treated in a single center with a mean follow-up of 14 years 9 months from the end of therapy. Med. Pediatr. Oncol, 1999, 33, 162.
108. SCHILLING F.H., SPIX C, BERTHOLD F. et al. - Neuroblastoma screening at one year of age. N. Engl. J. Med, 2002, 346, 1047-53.
109. PHILIP T. - Early detection of neuroblastoma in infants: Research? Yes. Routine Screening? No. Med. Pediatr. Oncol., 1999, 55, 355-6.